Deborah Ariosto1. 1. Vanderbilt University Medical Center, Nashville, TN.
Abstract
CONTEXT: Increasing regulatory incentives to computerize provider order entry (CPOE) and connect stores of unvalidated allergy information with the electronic health record (EHR) has created a perfect storm to overwhelm clinicians with high volumes of low or no value drug allergy alerts. Data sources include the patient and family, non-clinical staff, nurses, physicians and medical record sources. There has been little written on how to collect hypersensitivity information suited for drug allergy alerting. Opiates in particular are a frequently ordered class of drugs that have one of the highest rates of allergy alert override and are often a component of pre-populated Computerized Provider Order Entry (CPOE) order sets. Targeted research is needed to reduce alert volume, increase clinician acceptance, and improve patient safety and comfort. DESIGN SETTING AND PATIENTS: An FY10 retrospective, quantitative analysis of 30321 unique adults with opiate allergies triggering CPOE alerts at a large academic medical center. MEASUREMENTS: The prevalence of opiates ordered with opiate allergy alerts triggered and overridden is described. The effect of age, race, gender, visit type (medical, procedural), provider type (physician, advance practice nurse), and reaction/severity (e.g. nausea/mild) on the likelihood of provider override of the patient's first opiate alert was analyzed using Generalized Estimating Equations (GEE). RESULTS: Analysis of a patient's first opiate allergy alert (n=2767) showed that only prescriber role had a significant effect on alert override compared with all other variables in the model. Advanced practice nurses (APNs) were generally less likely to override the patient's first opiate alert as compared to physicians (GEE, β=-.793, β=.001). However, override rates remained high, with 80% for APN's and 90% for physicians. Over half of all discharges had opiates ordered during their stay. Of those, 9.1% of the patients had recorded opiate allergies triggering 25461 CPOE opiate allergy alerts. The largest sub-group of alerts was triggered by gastrointestinal (GI) "allergies" such as nausea and constipation. Removing these types of non-allergic, low severity GI reactions from the alert pool reduced the first alert volume by 15% and the overall alert volume by 22%. Of note is that a history of codeine allergy triggered a significant volume of opiate alerts, yet was rarely ordered. CONCLUSION: With an increasingly complex, information dependent healthcare culture, clinicians do not have unlimited time and cognitive capacity to interpret and effectively act on high volumes of low value alerts. Drug allergy alerting was one of the earliest and supposedly simplest forms of CPOE clinical decision support (CDS), yet still has unacceptably high override rates. Targeted strategies to exclude GI non-allergic type hypersensitivities, mild overdose, or adverse effects could yield large reductions in overall drug overrides rates. Explicit allergy and severity definitions, staff training, and improved clinical decision support at the point of allergy data input are needed to inform how we process new and re-process historical allergy data.
CONTEXT: Increasing regulatory incentives to computerize provider order entry (CPOE) and connect stores of unvalidated allergy information with the electronic health record (EHR) has created a perfect storm to overwhelm clinicians with high volumes of low or no value drug allergy alerts. Data sources include the patient and family, non-clinical staff, nurses, physicians and medical record sources. There has been little written on how to collect hypersensitivity information suited for drug allergy alerting. Opiates in particular are a frequently ordered class of drugs that have one of the highest rates of allergy alert override and are often a component of pre-populated Computerized Provider Order Entry (CPOE) order sets. Targeted research is needed to reduce alert volume, increase clinician acceptance, and improve patient safety and comfort. DESIGN SETTING AND PATIENTS: An FY10 retrospective, quantitative analysis of 30321 unique adults with opiate allergies triggering CPOE alerts at a large academic medical center. MEASUREMENTS: The prevalence of opiates ordered with opiate allergy alerts triggered and overridden is described. The effect of age, race, gender, visit type (medical, procedural), provider type (physician, advance practice nurse), and reaction/severity (e.g. nausea/mild) on the likelihood of provider override of the patient's first opiate alert was analyzed using Generalized Estimating Equations (GEE). RESULTS: Analysis of a patient's first opiate allergy alert (n=2767) showed that only prescriber role had a significant effect on alert override compared with all other variables in the model. Advanced practice nurses (APNs) were generally less likely to override the patient's first opiate alert as compared to physicians (GEE, β=-.793, β=.001). However, override rates remained high, with 80% for APN's and 90% for physicians. Over half of all discharges had opiates ordered during their stay. Of those, 9.1% of the patients had recorded opiate allergies triggering 25461 CPOE opiate allergy alerts. The largest sub-group of alerts was triggered by gastrointestinal (GI) "allergies" such as nausea and constipation. Removing these types of non-allergic, low severity GI reactions from the alert pool reduced the first alert volume by 15% and the overall alert volume by 22%. Of note is that a history of codeine allergy triggered a significant volume of opiate alerts, yet was rarely ordered. CONCLUSION: With an increasingly complex, information dependent healthcare culture, clinicians do not have unlimited time and cognitive capacity to interpret and effectively act on high volumes of low value alerts. Drug allergy alerting was one of the earliest and supposedly simplest forms of CPOE clinical decision support (CDS), yet still has unacceptably high override rates. Targeted strategies to exclude GI non-allergic type hypersensitivities, mild overdose, or adverse effects could yield large reductions in overall drug overrides rates. Explicit allergy and severity definitions, staff training, and improved clinical decision support at the point of allergy data input are needed to inform how we process new and re-process historical allergy data.
Authors: Heleen van der Sijs; Rachida Bouamar; Teun van Gelder; Jos Aarts; Marc Berg; Arnold Vulto Journal: Int J Med Inform Date: 2010-02-09 Impact factor: 4.046
Authors: D W Bates; J M Teich; J Lee; D Seger; G J Kuperman; N Ma'Luf; D Boyle; L Leape Journal: J Am Med Inform Assoc Date: 1999 Jul-Aug Impact factor: 4.497
Authors: Tyken C Hsieh; Gilad J Kuperman; Tonushree Jaggi; Patricia Hojnowski-Diaz; Julie Fiskio; Deborah H Williams; David W Bates; Tejal K Gandhi Journal: J Am Med Inform Assoc Date: 2004-08-06 Impact factor: 4.497
Authors: Maxim Topaz; Foster Goss; Kimberly Blumenthal; Kenneth Lai; Diane L Seger; Sarah P Slight; Paige G Wickner; George A Robinson; Kin Wah Fung; Robert C McClure; Shelly Spiro; Warren W Acker; David W Bates; Li Zhou Journal: Int J Med Inform Date: 2016-10-06 Impact factor: 4.046
Authors: Juan D Chaparro; Jonathan M Beus; Adam C Dziorny; Philip A Hagedorn; Sean Hernandez; Swaminathan Kandaswamy; Eric S Kirkendall; Allison B McCoy; Naveen Muthu; Evan W Orenstein Journal: Appl Clin Inform Date: 2022-05-25 Impact factor: 2.762
Authors: Sarah Patricia Slight; Patrick E Beeler; Diane L Seger; Mary G Amato; Qoua L Her; Michael Swerdloff; Olivia Dalleur; Karen C Nanji; InSook Cho; Nivethietha Maniam; Tewodros Eguale; Julie M Fiskio; Patricia C Dykes; David W Bates Journal: BMJ Qual Saf Date: 2016-03-18 Impact factor: 7.035
Authors: Liqin Wang; Suzanne V Blackley; Kimberly G Blumenthal; Sharmitha Yerneni; Foster R Goss; Ying-Chih Lo; Sonam N Shah; Carlos A Ortega; Zfania Tom Korach; Diane L Seger; Li Zhou Journal: J Am Med Inform Assoc Date: 2020-06-01 Impact factor: 4.497
Authors: Laura Légat; Sven Van Laere; Marc Nyssen; Stephane Steurbaut; Alain G Dupont; Pieter Cornu Journal: J Med Internet Res Date: 2018-09-07 Impact factor: 5.428
Authors: Maxim Topaz; Diane L Seger; Kenneth Lai; Paige G Wickner; Foster Goss; Neil Dhopeshwarkar; Frank Chang; David W Bates; Li Zhou Journal: Stud Health Technol Inform Date: 2015